Diabetes drug metformin tested as Anti-Aging treatment in prediabetic indians

NCT ID NCT07302932

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether metformin, a drug used for diabetes, can affect signs of aging in people with prediabetes. Researchers measured changes in telomere length and activity of longevity-related genes in 112 North Indian adults over six months. The goal was to see if metformin might slow aging at a cellular level, not to treat or cure any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METFORMIN, PREDIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Anoop misra

    New Delhi, National Capital Territory of Delhi, 110048, India